Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Occup Environ Med ; 81(2): 109-112, 2024 Feb 02.
Article in English | MEDLINE | ID: mdl-37932036

ABSTRACT

OBJECTIVES: To describe recent investigations of potential workplace cancer clusters. METHODS: We identified Health Hazard Evaluations (HHEs) of cancer concerns during 2001-2020. We described information about industry, requestors, cancer characteristics, investigative procedures, and determinations about the presence of a cluster (ie, presence of excess cases, unusual case distribution or exposure). RESULTS: Of 5754 HHEs, 174 included cancer concerns, comprising 1%-5% of HHEs per year. In 123 HHEs, the cancer cluster concerns involved different cancer primary sites. Investigation procedures varied but included record review (n=63, 36%) and site visits (n=22, 13%). Of 158 HHEs with a cluster determination by investigator(s), 151 (96%) were not considered cancer clusters. In seven HHEs, investigators found evidence of a cluster, but occupational exposure to a carcinogen was not identified. CONCLUSIONS: The proportion of HHEs on workplace cancer cluster concerns remained steady over time; most did not meet the definition of a cluster or uncover an occupational cause. Public health practitioners can use this information to provide updated context when addressing workplace cancer cluster concerns and as motivation to refine investigative approaches. More broadly, this review highlights an opportunity to identify best practices on how to apply community cluster investigation methods to the workplace.


Subject(s)
Neoplasms , Occupational Exposure , Occupational Health , Humans , Neoplasms/epidemiology , Occupational Exposure/adverse effects , Workplace
2.
Curr Opin Allergy Clin Immunol ; 21(2): 121-127, 2021 04 01.
Article in English | MEDLINE | ID: mdl-33394701

ABSTRACT

PURPOSE OF REVIEW: To examine respiratory and skin diseases that occur among workers exposed to metalworking fluids (MWFs) used during machining processes. RECENT FINDINGS: Five cases of a severe and previously unrecognized lung disease characterized by B-cell bronchiolitis and alveolar ductitis with emphysema (BADE) were identified among workers at a machining facility that used MWFs, although MWF exposure could not be confirmed as the etiology. In the United Kingdom, MWF is now the predominant cause of occupational hypersensitivity pneumonitis (HP). Under continuous conditions associated with respiratory disease outbreaks, over a working lifetime of 45 years, workers exposed to MWF at 0.1 mg/m3 are estimated to have a 45.3% risk of acquiring HP or occupational asthma under outbreak conditions and a 3.0% risk assuming outbreak conditions exist in 5% of MWF environments. In addition to respiratory outcomes, skin diseases such as allergic and irritant contact dermatitis persist as frequent causes of occupational disease following MWF exposure. SUMMARY: Healthcare providers need to consider MWF exposure as a potential cause for work-related respiratory and skin diseases. Additional work is necessary to more definitively characterize any potential association between MWF exposures and BADE. Medical surveillance should be implemented for workers regularly exposed to MWF.


Subject(s)
Air Pollutants, Occupational , Alveolitis, Extrinsic Allergic , Bronchiolitis , Occupational Diseases , Occupational Exposure , Skin Diseases , Alveolitis, Extrinsic Allergic/diagnosis , Alveolitis, Extrinsic Allergic/epidemiology , Humans , Metallurgy , Occupational Diseases/epidemiology , Occupational Exposure/adverse effects , Skin Diseases/chemically induced , Skin Diseases/epidemiology
3.
Am J Ind Med ; 62(10): 874-882, 2019 10.
Article in English | MEDLINE | ID: mdl-31332812

ABSTRACT

BACKGROUND: Cannabis has been legalized in some form for much of the United States. The National Institute for Occupational Safety and Health (NIOSH) received a health hazard evaluation request from a Minnesota cannabis facility and their union to undertake an evaluation. METHODS: NIOSH representatives visited the facility in August 2016 and April 2017. Surface wipe samples were collected for analysis of delta-9 tetrahydrocannabinol (Δ9-THC), delta-9 tetrahydrocannabinol acid (Δ9-THCA), cannabidiol, and cannabinol. Environmental air samples were collected for volatile organic compounds (VOCs), endotoxins (limulus amebocyte lysate assay), and fungal diversity (NIOSH two-stage BC251 bioaerosol sampler with internal transcribed spacer region sequencing analysis). RESULTS: Surface wipe samples identified Δ9-THC throughout the facility. Diacetyl and 2,3-pentanedione were measured in initial VOC screening and subsequent sampling during tasks where heat transference was greatest, though levels were well below the NIOSH recommended exposure limits. Endotoxin concentrations were highest during processing activities, while internal transcribed spacer region sequencing revealed that the Basidiomycota genus, Wallemia, had the highest relative abundance. CONCLUSIONS: To the authors' knowledge, this is the first published report of potential diacetyl and 2,3-pentanedione exposure in the cannabis industry, most notably during cannabis decarboxylation. Endotoxin exposure was elevated during grinding, indicating that this is a potentially high-risk task. The findings indicate that potential health hazards of significance are present during cannabis processing, and employers should be aware of potential exposures to VOCs, endotoxin, and fungi. Further research into the degree of respiratory and dermal hazards and resulting health effects in this industry is recommended.


Subject(s)
Agriculture , Air Pollutants, Occupational/analysis , Cannabis/chemistry , Inhalation Exposure/analysis , Occupational Exposure/analysis , Air Microbiology , Cannabidiol/analysis , Cannabinol/analysis , Dronabinol/analogs & derivatives , Dronabinol/analysis , Endotoxins/analysis , Humans , Minnesota , Volatile Organic Compounds/analysis
4.
J Occup Environ Med ; 56(1): 112-4, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24351887

ABSTRACT

The Occupational Medicine Forum is prepared by the ACOEM Occupational and Environmental Medical Practice Committee and does not necessarily represent an official ACOEM position. The Forum is intended for health professionals and is not intended to provide medical or legal advice, including illness prevention, diagnosis or treatment, or regulatory compliance. Such advice should be obtained directly from a physician and/or attorney.


Subject(s)
Aniline Compounds/poisoning , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Occupational Exposure/prevention & control , Occupational Health/standards , Anxiety/chemically induced , Dizziness/chemically induced , Dyspnea/chemically induced , Fatigue/chemically induced , Humans , Inservice Training/standards , Male , Protective Clothing , Respiratory Protective Devices , Seizures/chemically induced , Vomiting/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...